About: PK, Safety, and Tolerability Study of RBP-7000 of Different Molecular Weight Polymer in Subjects With Schizophrenia

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: PK, Safety, and Tolerability Study of RBP-7000 of Different Molecular Weight Polymer in Subjects With Schizophrenia Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

clinical trial

Attributes	Values
rdf:type	Item
description	clinical trial (en) ensayu clínicu (ast) klinisch onderzoek (nl) клінічне випробування (uk)
rdfs:label	PK, Safety, and Tolerability Study of RBP-7000 of Different Molecular Weight Polymer in Subjects With Schizophrenia (en) PK, Safety, and Tolerability Study of RBP-7000 of Different Molecular Weight Polymer in Subjects With Schizophrenia (nl)
skos:prefLabel	PK, Safety, and Tolerability Study of RBP-7000 of Different Molecular Weight Polymer in Subjects With Schizophrenia (en) PK, Safety, and Tolerability Study of RBP-7000 of Different Molecular Weight Polymer in Subjects With Schizophrenia (nl)
name	PK, Safety, and Tolerability Study of RBP-7000 of Different Molecular Weight Polymer in Subjects With Schizophrenia (en) PK, Safety, and Tolerability Study of RBP-7000 of Different Molecular Weight Polymer in Subjects With Schizophrenia (nl)
title	wds:Q65395973-090F336B-07F4-4260-A7EB-A51A2FAECE9F
title	A Multicenter, Randomized, Open-Label, Single-Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of RBP-7000 Using Poly (DL-lactide-co-glycolide) Polymer of Two Different Molecular Weights (Low and High Molecular Weights as Test Treatments) Compared to Intermediate Molecular Weight (Reference Treatment) Polymer in Subjects With Schizophrenia (en)
end time	wds:Q65395973-34A1149A-7089-4472-B185-203DAA84F4D0
end time	2016-05-01 00:00:00Z (xsd:dateTime)
instance of	wds:Q65395973-5F4F007E-882D-4B0E-8832-F06ED720423B
instance of	clinical trial
start time	wds:Q65395973-908B5DFE-7A8B-4DB9-8F8A-2A0F14605D2A
start time	2016-02-01 00:00:00Z (xsd:dateTime)
country	wds:Q65395973-E99366A8-50AA-4019-B977-575DEE4DF4BE
country	United States of America
research site	wds:Q65395973-DB1538FE-60E4-4E5A-BB81-099480E71A52
research site	Collaborative Neuroscience Network
research intervention	wds:Q65395973-B87D20A4-6352-4881-BF90-CC27F0374324
research intervention	risperidone
minimum age	wds:Q65395973-3CD67B1F-E92E-4418-ADA3-B53AFA647407
minimum age	18 (xsd:decimal)
medical condition	wds:Q65395973-F684CC75-97D1-49FC-8DE4-A7F349BC3D99
medical condition	schizophrenia
number of participants	wds:Q65395973-4C779E71-8A65-42CB-97F6-FF2C40DBC863
number of participants	44 (xsd:decimal)
maximum age	wds:Q65395973-6854FB76-FC29-4C1F-BEA5-43A44DF1C272
maximum age	65 (xsd:decimal)
study type	wds:Q65395973-8CA7CEB0-2286-4620-8575-8A2B27034755
study type	interventional study
ClinicalTrials.gov ID	wds:Q65395973-8C49985A-38A4-44D4-B857-CD38AF16EF93
ClinicalTrials.gov ID	NCT02687984
clinical trial phase	wds:Q65395973-A2368078-DF64-4029-A314-7C45EC32C3AD
clinical trial phase	phase I clinical trial
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q65395973

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software